NBMTX | PEMGX | NBMTX / PEMGX | |
Total Expense Ratio | 0.94 | 0.91 | 103% |
Annual Report Gross Expense Ratio | 0.94 | 0.91 | 103% |
Fund Existence | 32 years | 20 years | - |
Gain YTD | 14.041 | 4.528 | 310% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.12B | 33.2B | 6% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 10.71 | 1.76 | 609% |
Returns for 3 years | 41.09 | 51.27 | 80% |
Returns for 5 years | 4.27 | 42.83 | 10% |
Returns for 10 years | 42.08 | 107.11 | 39% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFSC | 29.55 | 0.05 | +0.16% |
F/m Emerald Life Sciences Innovation ETF | |||
BSCX | 21.57 | 0.02 | +0.09% |
Invesco BulletShares 2033 Corp Bd ETF | |||
PFF | 31.73 | -0.01 | -0.02% |
iShares Preferred&Income Securities ETF | |||
GTIP | 49.84 | -0.01 | -0.02% |
Goldman Sachs Acs Infl Protd USD Bd ETF | |||
APRJ | 24.65 | -0.03 | -0.12% |
Innovator Premium Income 30 Bar ETF -Apr |